Aska Pharmaceutical Holdings Co. Ltd. (4886) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Aska Pharmaceutical Holdings Co. Ltd. (4886:JPX), powered by AI.

Current Price
¥2,307
P/E Ratio
12.8
Market Cap
65.4B
Sector
Healthcare
What is the Aska Pharmaceutical Holdings Co. Ltd. stock price forecast?

Aska Pharmaceutical Holdings Co. Ltd. is currently trading at ¥2,307. View real-time AI analysis on Alpha Lenz.

What is Aska Pharmaceutical Holdings Co. Ltd. insider trading activity?

View the latest insider trading data for Aska Pharmaceutical Holdings Co. Ltd. on Alpha Lenz.

What is Aska Pharmaceutical Holdings Co. Ltd.'s P/E ratio?

Aska Pharmaceutical Holdings Co. Ltd.'s P/E ratio is 12.8.

Aska Pharmaceutical Holdings Co. Ltd.

JPX · 4886
¥2,307-55(-2.33%)Market closedJPX regular session 09:00–15:00 JST
Ask about Aska Pharmaceutical Holdings Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Aska Pharmaceutical Holdings Co. Ltd. trades at a P/E of 12.8 (undervalued) with solid ROE of 8.0%.

Ask for details

Company Overview

Aska Pharmaceutical Holdings Co. Ltd. is a prominent player in the pharmaceutical industry, focused on developing and manufacturing a wide array of medicinal products. Headquartered in Japan, Aska Pharmaceutical emphasizes the production of prescription drugs, over-the-counter medications, and active pharmaceutical ingredients. The company plays a critical role in the healthcare sector by supplying therapeutic solutions for various medical needs, including specialty areas such as endocrinology, urology, and obstetrics and gynecology. Aska Pharmaceutical Holdings Co. Ltd. stands out for its commitment to research and development, continuously aiming to innovate and improve treatment options available to healthcare professionals and patients alike. The firm operates within a highly regulated industry, emphasizing quality and safety in all of its processes. In a constantly evolving market, Aska Pharmaceutical leverages its expertise and infrastructure to address both domestic and international pharmaceutical demands, contributing significantly to the advancement of global health standards.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees1,632

Company Statistics

FY 2025

Profile

¥65,395,982,241Market Cap
¥64,139,000,000Revenue
0.00Shares Out
1,632Employees

Margins

48.85%Gross
13.67%EBITDA
8.31%Operating
9.65%Pre-Tax
7.95%Net

Valuation

12.82P/E
1.00P/B
1.02EV/Sales
7.93EV/EBITDA
-60.72P/FCF

Growth (CAGR)

4.25%Rev 3Yr
N/ARev 5Yr
3.60%Op Inc 3Yr
N/AOp Inc 5Yr
5.94%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

5.33%ROA
8.02%ROE
6.53%ROIC

Financial Health

¥10,603,000,000Cash & Cash Equivalents
¥20,737,000,000Net Debt
45.29%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Aska Pharmaceutical Holdings Co. Ltd. (ticker: 4886) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 1,632 employees. Market cap is $65.4B.

The current price is 2,307 with a P/E ratio of 12.82x and P/B of 1x.

ROE is 8.02% and operating margin is 8.31%. Annual revenue is $64.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Aska Pharmaceutical Holdings Co. Ltd. (4886) Stock Forecast 2026 ¥2,307 — Price, Financials & Analyst Targets | Alpha Lenz